Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT04134169
Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202)
Sponsor: Kang Stem Biotech Co., Ltd.
View on ClinicalTrials.gov
Summary
Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202)
Official title: A Multi-center, Open, Long-term Follow-up Study to Evaluate the Efficacy and Safety of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis : 5-year Results From the K0202 Extension Study
Key Details
Gender
All
Age Range
19 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
28
Start Date
2019-10-02
Completion Date
2026-04-11
Last Updated
2022-10-10
Healthy Volunteers
No
Conditions
Interventions
OTHER
Not applicable(observational study)
Not applicable(observational study)
Locations (1)
Seoul national University Boramae medical center
Seoul, South Korea